OR WAIT null SECS
December 13, 2023
Explore how Samsung Biologics’ DEVELOPICK™ can help mitigate development risk and identify candidates with the best potential for advancement to IND and beyond
December 06, 2023
In this application note, Pfizer CentreOne examines key considerations for the development and manufacturing of your unique sterile injectable.
November 20, 2023
Vetting a CMO for sterile injectable fill finish means more than capacity and equipment. This white paper from Jubilant HollisterStier discusses the range of factors to consider when outsourcing manufacturing for aseptically filled and terminally sterilized products.
November 08, 2023
September 06, 2023
KBI Biopharma has created a platform E.coli resulting in a PURE, efficient platform expression strain - PUREcoli™ - to reduce impurities and reach higher titers.
August 14, 2023
Expand your mAb NBE candidate pipeline numbers by leveraging ProtaGene's flexible analytical capacities. Get a complete overview of ProtaGene's end to end services.
April 18, 2023
For tech transfer of sterile injectables, vetting CMO partners means more than availability of facilities or the equipment, CMO partners should offer end-to-end support
October 21, 2022
A primer for understanding these remarkable therapies and their impacts in clinical trials.
July 30, 2021
June 23, 2020
In partnership with Honeywell, Axendia research sheds light on opportunities and challenges experienced by leaders trying to modernize their life sciences production.